Tuesday, March 17, 2026

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Google Glass Is Back—And Brin Thinks AI Can Finally Make It Work

Sergey Brin expresses renewed confidence in smart glasses, highlighting AI advancements for a better product after past failures.

South Korea Pushes a Unified Response to U.S. Trade Pressure: Why Non-Tariff Issues Are Now the Flashpoint

Yeo Han Koo emphasized the need for unified government action to address uncertainties in U.S.-Korea trade relations during a recent meeting.

Tag: revolutionary spirit

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.